Business Wire

WORLD-SURF-LEAGUE

Share
World Surf League Announces Partnership with Leading Global Beer Brand Corona; Multi-year Partnership Extends to Far Corners of the World

Today the World Surf League and Corona announced a multi-year partnership agreement through 2018, making Corona the Official Beer of the World Surf League globally, with the exception of the U.S. market.

“2015 was the single biggest year in surfing history across every major metric we measure, and we are thrilled that Corona – one of the Top 10 most valuable beer brands in the world according to BrandZ 2015 – has chosen to partner with us,” said Mark Noonan, Global Chief Commercial Officer of the World Surf League. “Corona’s aspirational lifestyle is a perfect complement to the WSL, and we are extremely proud to have them join our group of world class partners.”

The WSL and Corona will work together on consumer and customer activations in all key markets aligning Corona’s authentic and unpretentious lifestyle with the World Surf League’s mission of putting the world’s best surfers on the world’s best waves. Corona will engage surf fans through compelling original content, exciting on-site activations like the Corona Sunsets festivals, and corporate social responsibility initiatives at some of the most exotic and remote locations on the planet.

“Corona has been popular with surfers since the early 1980s, when surfers first discovered the point breaks of Baja and regularly enjoyed a crisp, refreshing Corona after catching the waves. We see The World Surf League as a great ambassador for our brand and the Corona lifestyle,” said Global VP Corona Marcel Marcondes. “Corona reminds us all to take a step back, reconnect to our essential nature and enjoy moments outside. This partnership with the WSL creates an abundance of such special moments in the most beautiful settings all year long. We believe the WSL provides us with a valuable opportunity to connect with the WSL’s growing community and LDA fans that are inspired by the surf lifestyle.”

Corona will partner with WSL Championship Tour surfers Coco Ho, Alejo Muniz, Matt Wilkinson and Julian Wilson. At each stop of the WSL Championship Tour, Corona will help ensure the experience of fans is unforgettable. Key markets for brand activations in 2016 will include Australia, Brazil, South Africa and France.

The 2016 Samsung Galaxy World Championship Tour begins with the Quiksilver Pro in Australia, kicking-off on March 10. Fans can catch all the live action by going to worldsurfleague.com or by downloading the free app in either the iTunes store or Google Play.

About The World Surf League

The World Surf League (WSL), formerly the Association of Surfing Professionals (ASP), is dedicated to celebrating the world’s best surfing on the world’s best waves through a variety of best-in-class audience platforms. The League, headquartered in Santa Monica, is a truly global sport with regional offices in Australasia, Africa, North America, South America, Hawaii, Japan and Europe.

The WSL has been championing the world's best surfing since 1976, running global events across the Samsung Galaxy Men's and Women's Championship Tours, the Big Wave Tour, Qualifying Series, Junior and Longboard Championships, as well as the WSL Big Wave Awards. The League possesses a deep appreciation for the sport's rich heritage while promoting progression, innovation and performance at the highest levels.

Showcasing the world's best surfing on its digital platform at WorldSurfLeague.com as well as the free WSL app, the WSL has a passionate global fan base with millions tuning in to see world-class athletes like Mick Fanning, John John Florence, Stephanie Gilmore, Greg Long, Gabriel Medina, Carissa Moore, Makua Rothman, Kelly Slater, Adriano de Souza and more battle on the most unpredictable and dynamic field of play of any sport in the world.

For more information, please visit WorldSurfLeague.com .

About Corona

Corona is the leading beer brand in Mexico, the 6th most valuable beer brand in the world*, and the most popular Mexican beer worldwide, with sales in more than 120 countries. Corona Extra was first brewed in 1925 at the Cervecería Modelo in Mexico City. Ten years after its launch, Corona became the best-selling beer in Mexico, and today continues to stand for Mexican pride around the world. Follow global Corona on Instagram: @corona

Contact:

World Surf League
Patty Smith, 310-804-2721
psmith@worldsurfleague.com
or
Corona
Karen Couck
karencouck@ab-inbev.com
or
Kathleen Van Boxelaer
kathleen.vanboxelaer@ab-inbev.com

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Alpega Group Completes Leadership Succession Plan Appointing Daniel Cohen New CEO8.1.2026 10:03:00 CET | Press release

Alpega Group, a leading pan-European provider of an end-to-end transportation and logistics platform, today announced a planned leadership transition. After a successful tenure as Chief Executive Officer, Todd DeLaughter will be retiring, stepping down from his role and transitioning to a Board Advisor role for the company. The Board of Directors has appointed Daniel Cohen as the incoming CEO, effective January 1st, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260108528648/en/ Daniel Cohen, CEO Alpega Daniel Cohen brings three decades of experience leading B2B SaaS businesses through periods of change, scale, and value realization. Most recently, as CEO of PayU, he led a full financial, operational, and cultural transformation returning the business to sustained profitable growth. He subsequently steered the company through a highly complex, multi-jurisdictional process that culminated in the successful sale to Rapyd

FPT Named Sitecore’s First Global Partner Under Global Elite Reseller Program8.1.2026 09:00:00 CET | Press release

Global IT Corporation FPT announced its appointment as the inaugural Global Elite Reseller under a new initiative from Sitecore that expands upon its successful Global Reseller Program. The Global Elite Reseller Program follows the launch of SitecoreAI, the next-generation digital experience platform that puts artificial intelligence at the center of marketing, unifying content, data, and personalization in one composable platform so organizations can reach, engage, and serve their audience across digital channels. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260107425261/en/ Representatives from FPT and Sitecore at the Global Elite Reseller signing ceremony. Under the agreement, FPT will hold exclusive reseller rights in Vietnam and non-exclusive rights across select markets in Asia and the Middle East, taking SitecoreAI to market and showing how it helps teams plan, create, and optimize digital experiences using AI as cu

Natus Sensory Appoints Arne Boye Nielsen to Board of Directors8.1.2026 08:00:00 CET | Press release

Natus Sensory, a global leader in sensory and diagnostic solutions, today announced the appointment of Arne Boye Nielsen to its Board of Directors, effective January 1, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260107392331/en/ Arne Boye Nielsen Arne brings more than 30 years of executive leadership experience in diagnostics and medical technology, most notably as President of Demant Diagnostics, where he built and scaled the business into a global leader over three decades. During his tenure, Arne played a central role in shaping Demant Diagnostics’ long-term strategy, portfolio expansion, and international growth, establishing it as a cornerstone of Demant’s global healthcare footprint. In addition to his executive leadership background, Arne brings extensive board experience. His deep expertise across diagnostics, governance, and value creation will further strengthen Natus Sensory’s Board as the company contin

4Moving Biotech Receives FDA IND Clearance for 4P004, Strengthening Its Position as a Leading Innovator in Disease-Modifying Osteoarthritis Therapeutics8.1.2026 07:30:00 CET | Press release

FDA IND clearance enabling the worldwide expansion of the INFLAM MOTION Phase 2a trial, involving major U.S. sites Advancing the first clinical proof of concept in OA with a first-in-class intra-articular GLP-1 agonist A holistic clinical strategy design establishing the foundation for a future accelerated approval pathway 4Moving Biotech (4MB), a clinical stage biotechnology company developing next-generation, disease-modifying therapies for osteoarthritis (OA), today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for 4P004, enabling the expansion of the Phase 2a INFLAM MOTION clinical trial into the United States (US). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260107798042/en/ 4Moving Biotech (4MB), a clinical stage biotechnology company developing next-generation, disease-modifying therapies for osteoarthritis (OA), today announced that the U.S. F

Organon Enters into a Commercialization Agreement for Daiichi Sankyo’s Nilemdo®in France, Denmark, Iceland, Sweden, Finland and Norway8.1.2026 07:30:00 CET | Press release

The agreement builds on Organon’s cardiovascular disease portfolio, leveraging expertise to expand access to new treatments for patients with dyslipidemia, especially statin-intolerant patients.This collaboration addresses a critical gap in care that disproportionately affects women, who are at a 47% higher risk of developing statin intolerance compared to men.i Organon today announced that it has entered into an agreement with Daiichi Sankyo Europe to commercialize Nilemdo® (bempedoic acid) in France, Denmark, Iceland, Sweden, Finland and Norway. Nilemdo® is a new, first-in-class drug indicated for patients with high cholesterol and cardiovascular disease risk. It provides an alternative treatment for patients that cannot be treated effectively with statins.ii “This collaboration combines Organon’s commercial agility with Daiichi Sankyo’s expertise in cardiovascular innovation to bring Nilemdo® to patients in France, Denmark, Iceland, Sweden, Finland and Norway,” says Thibault Crosnie

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye